SLC5A2 and diabetes mellitus: DKA is rare in patients taking SGLT2 inhibitors.66 A systematic reviewand meta-analysis of RCTs found that SGLT2 inhibitors have been associatedwith cases of DKA in patients with diabetes, but not in patients withoutdiabetes.